Are p27 and p21 cytoplasmic oncoproteins?

Mikhail V Blagosklonny1

  • 1Brander Cancer Research Institute, 19 Bradhurst Ave, Suite 2400, Hawthorne, New York 10532, USA. M_Blagosklonny@NYMC.EDU

Insights

The Akt oncogenic kinase inactivates tumor suppressor proteins p27 and p21 by moving them to the cytoplasm. Evidence suggests these proteins may gain new antiapoptotic functions in the cytoplasm, acting as oncoproteins.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • The Akt oncogenic kinase plays a role in cell proliferation and survival.
  • Nuclear tumor suppressor proteins p27 and p21 regulate the cell cycle and apoptosis.
  • Mislocalization of tumor suppressors can contribute to cancer development.

Purpose of the Study:

  • To investigate the functional consequences of cytoplasmic mislocalization of p27 and p21.
  • To determine if cytoplasmic p27 and p21 acquire new functions.
  • To explore the potential antiapoptotic roles of cytoplasmic p27 and p21.

Main Methods:

  • The study likely involved cell-based assays to track protein localization.
  • Techniques such as Western blotting and immunofluorescence may have been used.
  • Functional assays assessing apoptosis and cell cycle progression were probably employed.

Main Results:

  • Akt oncogenic kinase induces cytoplasmic mislocalization of p27 and p21.
  • Cytoplasmic localization of p27 and p21 is associated with altered cellular functions.
  • Preliminary data suggest these cytoplasmic proteins exhibit antiapoptotic activities.

Conclusions:

  • Cytoplasmic mislocalization of p27 and p21 by Akt is not merely functional inactivation.
  • p27 and p21 may acquire oncogenic, antiapoptotic functions in the cytoplasm.
  • These findings highlight a novel mechanism in Akt-mediated oncogenesis.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...